Chargement en cours...
Current Status of Immunotherapy for Localized and Locally Advanced Renal Cell Carcinoma
Systemic therapy strategies in the setting of localized and locally advanced renal cell carcinoma (RCC) have continued to evolve in two directions: as adjuvant therapy (to reduce risk of recurrence or progression in high risk localized groups), or as neoadjuvant therapy as a strategy to render prima...
Enregistré dans:
| Publié dans: | J Oncol |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Hindawi
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6463563/ https://ncbi.nlm.nih.gov/pubmed/31057615 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/7309205 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|